Contact Us: 01282 426380
KM Financial Solutions | Biotech CEO, two associates accused by U.S. of securities fraud
15465
post-template-default,single,single-post,postid-15465,single-format-standard,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode_grid_1300,footer_responsive_adv,hide_top_bar_on_mobile_header,qode-child-theme-ver-1.0.0,qode-theme-ver-11.2,qode-theme-bridge,wpb-js-composer js-comp-ver-5.2.1,vc_responsive
 

Biotech CEO, two associates accused by U.S. of securities fraud

23 Apr Biotech CEO, two associates accused by U.S. of securities fraud

Posted at 22:52h in News by
0 Likes
BOSTON, April 24 (Reuters) – The chief executive of a
biotech company that said it was developing a non-opiate pain
treatment was arrested along with two associates on Tuesday on
U.S. charges that he misled investors and participated in a
stock manipulation scheme.

No Comments

Sorry, the comment form is closed at this time.